These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 18818286)

  • 1. Mouse models of Alzheimer's dementia: current concepts and new trends.
    Torres-Aleman I
    Endocrinology; 2008 Dec; 149(12):5952-7. PubMed ID: 18818286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential roles of insulin and IGF-1 in Alzheimer's disease.
    Gasparini L; Xu H
    Trends Neurosci; 2003 Aug; 26(8):404-6. PubMed ID: 12900169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin growth factor binding protein 7 is a novel target to treat dementia.
    Agbemenyah HY; Agis-Balboa RC; Burkhardt S; Delalle I; Fischer A
    Neurobiol Dis; 2014 Feb; 62():135-43. PubMed ID: 24075854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early brain amyloidosis in APP/PS1 mice with serum insulin-like growth factor-I deficiency.
    Poirier R; Fernandez AM; Torres-Aleman I; Metzger F
    Neurosci Lett; 2012 Feb; 509(2):101-4. PubMed ID: 22230888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Animal models of dementia and cognitive dysfunction.
    Neha ; Sodhi RK; Jaggi AS; Singh N
    Life Sci; 2014 Jul; 109(2):73-86. PubMed ID: 25066372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What is 'early onset dementia'?
    Miyoshi K
    Psychogeriatrics; 2009 Jun; 9(2):67-72. PubMed ID: 19604328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of the insulin-like growth factor I receptor in the choroid plexus originates Alzheimer's-like neuropathology in rodents: new cues into the human disease?
    Carro E; Trejo JL; Spuch C; Bohl D; Heard JM; Torres-Aleman I
    Neurobiol Aging; 2006 Nov; 27(11):1618-31. PubMed ID: 16274856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetes as a risk factor for Alzheimer's disease: insulin signalling impairment in the brain as an alternative model of Alzheimer's disease.
    Hölscher C
    Biochem Soc Trans; 2011 Aug; 39(4):891-7. PubMed ID: 21787319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The behavioral, pathological and therapeutic features of the senescence-accelerated mouse prone 8 strain as an Alzheimer's disease animal model.
    Cheng XR; Zhou WX; Zhang YX
    Ageing Res Rev; 2014 Jan; 13():13-37. PubMed ID: 24269312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New animal models of Alzheimer's disease that display insulin desensitization in the brain.
    Gao C; Liu Y; Li L; Hölscher C
    Rev Neurosci; 2013; 24(6):607-15. PubMed ID: 24259244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impairment of insulin signaling in Alzheimer's disease.
    Candeias E; Duarte AI; Carvalho C; Correia SC; Cardoso S; Santos RX; Plácido AI; Perry G; Moreira PI
    IUBMB Life; 2012 Dec; 64(12):951-7. PubMed ID: 23129399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transgenic mouse models of Alzheimer's disease: phenotype and application.
    Higgins GA; Jacobsen H
    Behav Pharmacol; 2003 Sep; 14(5-6):419-38. PubMed ID: 14501255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dementia, diabetes, Alzheimer's disease, and insulin resistance in the brain: progress, dilemmas, new opportunities, and a hypothesis to tackle intersecting epidemics.
    Kuljiš RO; Salković-Petrišić M
    J Alzheimers Dis; 2011; 25(1):29-41. PubMed ID: 21335659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic actions of insulin-like growth factor I on APP/PS2 mice with severe brain amyloidosis.
    Carro E; Trejo JL; Gerber A; Loetscher H; Torrado J; Metzger F; Torres-Aleman I
    Neurobiol Aging; 2006 Sep; 27(9):1250-7. PubMed ID: 16183170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug development in dementia.
    Cunningham EL; Passmore AP
    Maturitas; 2013 Nov; 76(3):260-6. PubMed ID: 23707728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of insulin and insulin-like growth factor I in the molecular and cellular mechanisms underlying the pathology of Alzheimer's disease.
    Carro E; Torres-Aleman I
    Eur J Pharmacol; 2004 Apr; 490(1-3):127-33. PubMed ID: 15094079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drosophila as a model to study age-related neurodegenerative disorders: Alzheimer's disease.
    Bonner JM; Boulianne GL
    Exp Gerontol; 2011 May; 46(5):335-9. PubMed ID: 20719244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selecting a mouse model of Alzheimer's disease.
    Chin J
    Methods Mol Biol; 2011; 670():169-89. PubMed ID: 20967591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative analysis of cortical gene expression in mouse models of Alzheimer's disease.
    Wu ZL; Ciallella JR; Flood DG; O'Kane TM; Bozyczko-Coyne D; Savage MJ
    Neurobiol Aging; 2006 Mar; 27(3):377-86. PubMed ID: 15927307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.